Vorolanib

CAS No. 1013920-15-4

Vorolanib( CM082,X-82 )

Catalog No. M21932 CAS No. 1013920-15-4

Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 250 In Stock
2MG 145 In Stock
5MG 227 In Stock
10MG 359 In Stock
25MG 616 In Stock
50MG 870 In Stock
100MG 1181 In Stock
200MG 1572 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vorolanib
  • Note
    Research use only, not for human use.
  • Brief Description
    Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.
  • Description
    Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CM082,X-82
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR|PDGFR
  • Research Area
    Urinary system/Cancer
  • Indication
    Renal Cell Cancer Metastatic

Chemical Information

  • CAS Number
    1013920-15-4
  • Formula Weight
    439.48
  • Molecular Formula
    C23H26FN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:22 mg/ml (50.06 mM; Need ultrasonic)
  • SMILES
    CN(C)C(=O)N1CC[C@@H](C1)NC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr;24(4):455-e121.
molnova catalog
related products
  • SU5204

    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).

  • TG 100801

    TG 100801 is a dual inhibitor of VEGFr2 and Src family (Src and YES) kinases and is a candidate compound for the treatment of age-related macular degeneration (AMD).

  • Brivanib alaninate

    A prodrug of Brivanib, which is a dual inhibitor of VEGFR2 and FGFR1 with IC50 of 25 nM and 148 nM respectively.